| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |